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Oxidative stressRecent studies have demonstrated that carbon nanotubes (CNTs) induce platelet aggregation, endothelial
dysfunction and vascular thrombosis. However, there is little information on the effects of CNTs on
ﬁbrinolysis. We investigated the role of pristine-commercial single-walled carbon nanotubes
(SWCNTs) with <3% Co content in ﬁbrinolysis and their contribution to the induction of pro-thrombotic
processes in human vein endothelial cells (HUVEC). SWCNTs alone produced concentration-dependent
oxidation, as measured by a dithiothreitol oxidation assay. Internalized SWCNTs were located in
HUVEC treated with 25 lg/ml using transmission electron microscopy, whereas treatment with 50 lg/
ml compromised cell viability, and oxidative stress increased signiﬁcantly at 5 lg/ml. The study showed
that in HUVEC treated with 25 lg SWCNT/ml, ﬁbrinolysis-related gene expression and protein levels had
increased by 3–12 h after treatment (serpine-1: 13-fold; PLAT: 11-fold and PLAU: 2-fold), but only the PAI-
1 protein was increased (1.5-fold), whereas tissue and urokinase plasminogen activator proteins (tPA and
uPA, respectively) tended to decrease. In summary, pristine SWCNTs treatment resulted in evident
HUVEC damage caused by cell ﬁber contact, internalization, and oxidative stress due to contaminant
metals. The generation of endothelial dysfunction, as shown by the altered expression of genes and pro-
teins involved in ﬁbrinolysis, suggest that SWCNTs display pro-thrombotic effects.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction Carbon nanotubes (CNTs) are a case in point as, since their discov-At present, nanomaterials have become a valuable raw material
used in industry for numerous products with special properties.ery in 1991 (Iijima, 1991), they have attracted great scientiﬁc
research and technological attention due to their simple chemical
composition, extraordinary properties and versatile applications.
However, the human risk of exposure to nanomaterials has not
yet been fully characterized (for a review, see Rodriguez-Yanez
et al. (2013)). Exposure to CNTs may occur in an occupationally
context or derived from the possible use as medical devices. Also,
due to the increasing production and use of CNTs, also will increase
their release to the environment during their production process.
For these reasons, respiratory and vascular system represent a por-
tal of entry of CNTs. Nevertheless, several research groups have
studied the biodistribution pathway using different animal models.
It is clear that CNT-toxicokinetics depends on the shape, physico-
chemical properties, impurities and agglomeration of pristine
CNTs. These characteristics also determine the CNT-deposition in
different regions of the respiratory tract when they are inhaled.
To date, there are only a few studies that explain the toxicokinetic
Table 1
Physicochemical characterization of SWCNTs.
Property Characterization
Purity 95% CNT, 90% SWCNT
Average outside diameter 1–2 nm
Inside diameter 0.8–1.6 nm
Length 1–3 lm
Impurities/contaminants
Transition metals Co < 3%
Other elements Al < 0.1%, Cl < 0.5%, S < 0.3%
Stock#: 1246YJS. Manufacturing method: Catalytic CVD. Analysis Method: Energy
Dispersive X-ray Spectroscopy, as reported by the supplier.
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intra-tracheal instillation or intravenous injection, and explain
the effects on respiratory and systemic blood circulation. It is pos-
sible that after their deposition, CNTs are able to translocate to
extrapulmonary sites (Bussy et al., 2013; Ali-Boucetta and
Kostarelos, 2013). In this context, Erdely et al. (2013) reported a
relationship between pulmonary deposition and systemic circula-
tion, where the CNTs may induce both pulmonary and systemic
effects characterized by a blood gene and protein expression pat-
tern. Once CNTs enter the general circulation, they may interact
with blood cells, plasma proteins and endothelial cells (ECs).
ECs form a single cell layer called the endothelium, which is
localized at the luminal face of the blood vessels and plays a key
physiological role in the regulation of ﬁbrinolysis mechanisms
through the expression of pro-thrombotic and anti-thrombotic fac-
tors in close relationship with smooth muscle cells and the extra-
cellular matrix (Baudin et al., 2007). Human umbilical vein
endothelial cells (HUVEC) represent a good model commonly used
for physiological, pharmacological and toxicological investigations,
such as blood coagulation, macromolecule transport, angiogenesis
and ﬁbrinolysis (Bachetti and Morbidelli, 2000) and also for the
study of endothelial cell functions due to the fact that they are both
anatomically and physiologically representative of arterial blood
vessels. Thus, moreover, represents a ﬁrst approach to the search
for mechanisms to explain cellular alterations due to diseases or
to the presence of toxic agents.
Fibrinolysis is a complex processwithmany steps and the partic-
ipation of numerousmolecules, e.g., (a) plasminogen, a pro-enzyme
that is converted into plasmin, the active enzyme, depending on the
presence of plasminogen activators (PAs), such as tissue-plasmino-
gen activator (tPA) and urokinase-plasminogen activator (uPA), and
their inhibitors (PAIs), especially plasminogen activator-1 (PAI-1);
(b) the kallikrein-kinin system (KKS), particularly tissue kallikrein
(KLK1), which promotes ﬁbrinolysis by stimulating the release of
tPA from ECs (Brown et al., 2000; Bhoola et al., 1992).
In vivo, exposure to CNTs results in endothelial dysfunction
with neutrophil adhesion to the endothelial monolayer through
increases in the expression of adhesion molecules via nuclear NF-
jB/P65 translocation, as well as oxidative stress (Zhiqing et al.,
2010), the induction of platelet aggregation and an increase in
thrombus formation, leading to a decrease in the occlusion time
in small mesenteric arteries, which increases vascular thrombosis
(Radomski et al., 2005; Bihari et al., 2010). In addition, CNTs affect
platelets, which are essential to the coagulation process, promoting
their activation in vitro leading to their aggregation and viability
loss. This process is associated with Ca2+ inﬂux and its depletion
from intracellular stores (Lacerda et al., 2011; Semberova et al.,
2009; Meng et al., 2012), increases in both P-selectin expression
and the number of platelet-granulocyte complexes (Bihari et al.,
2010), and an up-regulation of glycoprotein integrin receptor
GPIIb/IIIa, all of which are crucial for platelet aggregation
(Radomski et al., 2005). Additionally, CNTs cause different degrees
of red blood cell damage, leading to earlier ﬁbrin formation that
might signiﬁcantly increase the hardness of the clots (Meng
et al., 2012).
In spite of the increasing experimental data on the pulmonary
effects of CNTs, at present, there are few studies focused on the
effects of CNTs on the vascular endothelium, especially toward
the coagulation system.
Due to the lack of information about the mechanism by which
CNTs may affect ﬁbrinolysis, we investigated the effects of com-
mercial and pristine SWCNTs on primary cultures of human
umbilical vein endothelial cells (HUVEC) in vitro by assessing the
expression of genes/proteins associated with plasminogen activa-
tion (Serpine-1/PAI-1, PLAT/tPA, PLAU/uPA), vascular homeostasis
(KLK1) and endothelial dysfunction, because ECs might interactwith this nanomaterial. In addition, the intrinsic SWCNTs oxidative
potential, their cell internalization and their capacity to produced
oxidative stress were also studied.2. Materials and methods
2.1. Carbon nanotubes suspension in culture media
A single-walled carbon nanotubes (SWCNTs) stock was pur-
chased as dry powder from Nanostructured & Amorphous
Materials, Inc. (Houston, TX); the physicochemical characterization
of SWCNTs is shown in Table 1. The powder sample was dissolved
in sterile deionized (DI) H2O using a biosafety cabinet class III (Esco
Technologies, Inc., Singapore, Sin) at a concentration of 4 mg/ml.
The stock solution was prepared as previously described (Wang
et al., 2010a). The mixture was suspended by sonication at 90 W
for 15 min (Branson, Danbury, CT) and used as a stock solution.
An appropriate amount of the SWCNT stock solution was added
to the culture media to obtain the desired ﬁnal concentration.
The diluted suspensions were vortexed for 15 s, then sonicated
for 15 min and vortexed again for 15 s. Here, we used fetal bovine
serum (FBS) (Gibco-Life Technologies) as a SWCNT-dispersing
agent, and it was added to the culture media before the addition
of SWCNTs at a 1% v/v ﬁnal concentration. Thereafter, we
characterized the SWCNT-suspension by assessing its stability
index through monitoring the sedimentation kinetics of the sus-
pension’s absorbance at 550 nm for different lengths of time in a
UV–VIS spectrophotometer (Inﬁnite M200, Tecan Austria GmbH,
Austria). An aliquot (1 ml) of the SWCNT-suspension containing
50 lg/ml was prepared with or without FBS, and the absorbance
readings were taken at 1 hour-time intervals for 24 h (data not
shown).
2.2. Dithiothreitol assay and oxidative activity
The intrinsic redox activity was adapted for SWCNTs from the
assay based on the ability of particulate matter components to
act as electron transfer agents between dithiothreitol (DTT), as
the electron source, and oxygen, as the electron acceptor
(Kumagai et al., 2002). The remaining thiol content was allowed
to react with DTNB, generating 5-mercapto-2-nitrobenzoic acid,
and measured at 412 nm in a spectrophotometer. Brieﬂy, the
SWCNT-suspensions (0.01–50 lg corresponding to the following
theoretical molarities: 2.94  1015 – 6.32  1016 to 1.47 
1011 – 3.16  1012, as considering the lower and higher
SWCNTs dimension limits; http://www.nanointegris.com/en/
hipco) were incubated at 37 C with 0.5 M PBS, pH 7.4, DI H2O
and 1 mM DTT (Sigma–Aldrich) for 0–45 min. Subsequently, 10%
trichloroacetic acid (Sigma–Aldrich) was added to an aliquot of
the incubation mixture to stop the reaction. Next, an aliquot of
the last mixture was dissolved with Tris buffer, pH 8.9, with
20 mM EDTA and 10 mM DTNB (Sigma–Aldrich) solution and
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Tecan Austria GmbH, Austria). Redox activity was expressed as the
rate of DTT consumption (nmol) per minute per microgram of sam-
ple minus the activity observed in the absence of SWCNTs.
2.3. Endothelial primary cell culture
HUVEC were obtained by collagenase digestion by pooling 8–10
umbilical cords per culture plate, obtained from independent
donors (all provided by Hospital General de Ticoman-SSDF;
Ethical approval by the Hospital Ethics Committee: E1/230/2012).
The phenotype of HUVEC cultures was conﬁrmed by VE-cadherin
antigen staining and were cultured in M199 medium (Gibco-Life
Technologies) supplemented with 10% FBS, 20 lg/ml endothelial
mitogen (Sigma–Aldrich) and 1 mg/ml heparin (Pisa pharmaceuti-
cal). For the experiments, the HUVEC were always used after the
second passage and maintained in DMEM without phenol red
(Sigma–Aldrich), with 1% FBS, for 12 h prior to exposure.
Subsequently, the HUVEC were exposed to SWCNTs at concentra-
tions of 0.01–25 lg/ml, except for speciﬁcally indicated assays,
and to tumor necrosis factor-alpha (TNF-a) (Invitrogen-Life
Technologies) (10 ng/ml) as a positive control of endothelial
activation. Likewise, for some experiments, an antioxidant group
was included with the same SWCNTs concentration plus Trolox
(Sigma–Aldrich) (50 lg/ml, ﬁnal concentration).
2.4. Cell viability
Propidium iodide (PI) is a membrane-impermeable dye that is
generally excluded from viable cells. It binds to double stranded
DNA by intercalating between base pairs. PI is excited at 488 nm
and, with a relatively large Stokes shift, emits at a maximumwave-
length of 617 nm. Brieﬂy, control and SWCNT-treated HUVEC
(1  106 cells/100 ll) were placed into FACS tubes and washed
two times by adding 2 ml of PBS, centrifuging and the decanting
the buffer from the pelleted cells. The cells were re-suspended in
200 ll of staining buffer that contained 10 lg/ml PI (Sigma–
Aldrich) in PBS. The mixture was mixed gently and incubated for
1 min in the dark. The PI ﬂuorescence was determined using an
FL-2 channel with a ﬂow cytometer (BD FACSCalibur Flow
Cytometer; BD Biosciences, San Jose, CA), and at least 10,000
events were used for each measurement.
2.5. Transmission electron microscopy (TEM)
The SWCNT-structure was characterized by TEM. The SWCNT-
suspension (5 lg/ml) was deposited in a gold-grid, and the sample
was dried and analyzed in a conventional transmission electron
microscope (C-TEM) (Jeol JEM 1011, Tokio, Japan) and in a high-
resolution transmission electron microscope (HR-TEM) (Jeol JEM-
ARM200F, Tokyo, Japan). Images were taken at different magniﬁca-
tions at 80 kV.
On the other hand, cell SWCNT-internalization was observed in
treated HUVEC ﬁxed in 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer for 24 h at 4 C. The samples were washed with
the same buffer and post-ﬁxed with 1% osmium tetroxide contain-
ing 0.8% potassium ferrocyanide. The samples were dehydrated
with ethanol (70%, 80%, 90% and absolute) and detached with a fast
propylene oxide treatment. After incubation in a mixture of propy-
lene oxide-epoxy resin (1:1) for 24 h, the samples were embedded
in the epoxy resin POLY/BED 812 (Polysciences, Inc. Warrington,
UK) and polymerized for 24 h at 60 C. Then, 60 nm sections were
sieved in 300 mesh cupper-grids and contrasted with uranyl acet-
ate and lead citrate. The sections were examined in a Jeol JEM 1011
and JEM-ARM200F microscopes at 80 kV.2.6. Index of oxidative stress
This assay is based on the use of dichloroﬂuorescein diacetate
(H2DCFDA), a cell permeable, non-ﬂuorescent reagent cleaved by
intracellular esterases to produce the cell membrane-im-
permeable, non-ﬂuorescent product H2DCF, which accumulates
intracellularly, where it is oxidized to the highly ﬂuorescent
dichloroﬂuorescein (DCF). The redox state of the sample can be
monitored by detecting the increase in ﬂuorescence measured at
530 nmwhen the sample is excited at 485 nm. Brieﬂy, 1  106 cells
were incubated in a 6-well plate, and after treatment with SWCNTs
(0.01–50 lg/ml) for 2 h, the cells were washed, and the medium
was replaced with PBS. H2DCFDA (Sigma–Aldrich) was dissolved
in methanol (10 mM) and added to PBS for a ﬁnal concentration
of 5 lM, and the cells were incubated at 37 C for 30 min in the
dark. The cells were washed with PBS, then trypsinized and
washed again with PBS. The mixture was centrifuged, and the
supernatant decanted. The cell pellet was re-suspended in 200 ll
of PBS, covered and kept away from light. The ﬂuorescence was
determined using a FL-1 channel with a ﬂow cytometer (BD
FACSCalibur Flow Cytometer; BD Biosciences, San Jose, CA), and
at least 10,000 events were used for each measurement.
2.7. RNA isolation
Total RNA was extracted from control and SWCNT-treated cells
using TRIzol reagent (Invitrogen-Life Technologies) according to
the manufacturer’s instructions. The RNA concentration and purity
were estimated by optical density at 260/280 nm, and its integrity
was assessed by electrophoresis on 1% agarose gels stained with
ethidium bromide. Isolated RNA was stored at 70 C until
analysis.
2.8. Complementary DNA (cDNA) synthesis and real-time polymerase
chain reaction (PCR)
cDNA was synthesized using ampliﬁcation grade DNAse and
SuperScript III First-strand synthesis system (Invitrogen-Life
Technologies) according to the manufacturer’s instructions. Real-
time PCR reactions were carried out in a CFX96 Real-time PCR
Detection system (BioRad Laboratories Inc., Hercules, CA) using
the TaqMan Universal PCR Master Mix (Applied Biosystems-Life
Technologies). In a ﬁnal volume of 15 ll, 1 ll of cDNAwas ampliﬁed
using the following Taqman gene expression assays (Applied
Biosystems-Life Technologies): Serpine-1 (Hs01126606_m1), PLAT
(Hs00938315_m1), PLAU (Hs01547054_m1), KLK1
(Hs00158490_m1) and GAPDH (Hs02758991). The relative mRNA
levels were calculated according to the comparative Ct method,
using GAPDH as a housekeeping gene.
2.9. PAI-1, tPA, and uPA quantitation
Cell culture supernatants of both control and SWCNT-treated
cells were used after a speciﬁed time of exposure. Brieﬂy, the
PAI-1, tPA and uPA were assessed using commercially available
enzyme-linked immunosorbent assay (ELISA) kits (Abcam) and
according to the suppliers indications. Polyclonal antibodies speci-
ﬁc for each antigen were pre-coated onto a microplate. The antigen
in standards and samples (cell culture supernatants) was sand-
wiched by the immobilized antibody and a biotinylated polyclonal
antibody speciﬁc for each antigen, which was recognized by strep-
tavidin-peroxidase conjugating agent. All unbound material was
then washed away, and a peroxidase enzyme substrate was added.
Color development was stopped as indicated, and its intensity was
measured in a microplate reader (Inﬁnite M200, Tecan Austria
GmbH, Austria).
Table 2
Contaminants reported on CNT material used in vitro and in vivo studies.
Metal % Material CNT concentration References
Fe 30 0.06–0.24 mg/l Shvedova et al. (2003)
0.23 0–40 lg/mouse Shvedova et al. (2005)
0.23 0–96 lg/cm2 Kisin et al. (2007)
17.7 5–20 lg/mouse Shvedova et al. (2008)
10 0.01–1 mg/l Guo et al. (2008)
0.07 5 and 50 lg/cm2 Pacurari et al. (2008)
Raw: 30;
Puriﬁed: 0.23
75 mg/ml;
60–240 lg/ml
Murray et al. (2009)
0.32 10–80 lg/mouse Porter et al. (2010)
Fe, Ni, Cu Raw: 26.9, 0.1–0.5 mg/mouse Lam et al. (2004)
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The results shown are the mean values ± the standard error of
the mean (SEM) of three independent experiments performed in
triplicate. Data were analyzed using one-way analysis of variance
(ANOVA), followed by Dunnet’s post hoc test. qPCR data were ana-
lyzed using the Kruskal–Wallis/one-way ANOVA, followed by
Dunn’s post hoc test.
All statistical analyses were performed by Graphpad Prism soft-
ware version 6.0 (Graphpad Software Inc. San Diego, CA).
Differences were considered statistically signiﬁcant at ⁄p < 0.05 or
⁄⁄p < 0.01.0.78, 0.36
Puriﬁed: 2.14
Fe, Co <1.3, <0.4 7.5–30 lg/ml Wick et al. (2007)
Fe, Ni, Y 10, 3, 2 0–0.8 mg/ml Casey et al. (2008)
10, <1, <1 0–400 lg/ml Herzog et al. (2007)
Co, Ni 2.5 50 lg/ml Worle-Knirsch et al. (2006)
5 0–50 mg/kg Warheit (2009)
Co <3 0.01–50 lg/ml This study3. Results
3.1. SWCNT characterization
Physicochemical characteristics and TEM micrograph of the
SWCNTs used in this study are shown in Table 1 and Fig. 1, respec-
tively. The external diameter of a CNT was 1–2 nm, which is in
accordance with the deﬁnition of nanomaterial. Ninety-ﬁve per-
cent of the material supplied were CNTs and of these, ninety per-
cent were SWCNTs. Co was the main impurity (<3%), and other
elements were present at low concentrations. The CNTs contained
metals that were used in their fabrication and were difﬁcult to
remove; these metals are considered impurities or contaminants
and should be considered when interpreting the results. The metal
content in the CNTs used in other investigations is shown in
Table 2, with Co concentrations ranking from 0.4% to 5% of the
raw material weigh; however, some other elements could be pre-
sent at even higher concentrations. Thus, each study of CNTs can
be considered independent, with ﬁndings reﬂecting only their par-
ticular composition.3.2. Intrinsic REDOX activity of SWCNTs
An assessment of the oxidative ability of pristine SWCNTs was
conducted using a DTT assay. The results show that SWCNTs had
a high DTT oxidative capacity in a concentration-dependent man-
ner, which was signiﬁcant at 5 lg/ml and above (Fig. 2). SWCNTs
contain some elements used in their fabrication; in this case, the
content of Co, a transition metal, was <3%, and that of other
elements was <1%. Thus, the DTT assay indicated the possibleFig. 1. Representative micrograph of SWCNTs. TEM images of SWCNTs (Jeol JEM
1011 operated at 80 kV).oxidation capacity of both SWCNTs and their contaminating
metals. This oxidative capacity may promote oxidative cell
damage.
3.3. SWCNT cytotoxicity on HUVEC
HUVEC were exposed to pristine SWCNTs (5–500 lg/ml) for
24 h to assess cell viability with the PI method. Increasing concen-
trations of SWCNTs resulted in a decrease in HUVEC viability that
reached statistical signiﬁcance at 50 lg SWCNTs/ml and above
compared with untreated control cell cultures. At 50 lg SWCNTs/
ml, cell viability decreased approximately 20%, and the decrease
was even higher when exposed to 100 lg/ml (Fig. 3). Based on
these results, all of our subsequent experiments with HUVEC were
performed using concentrations ranging from 0.01 to 50 lg
SWCNTs/ml.
3.4. Cellular redox state
It is well known that H2DCFDA cannot be used as direct mea-
sure of ROS due to it reacts with several one-electron oxidizing
species (e.g. hydroxyl radicals) or redox-active metalsFig. 2. REDOX activity of SWCNTs assessed by dithiothreitol assay. Activity is
expressed as the rate of DTT consumption after a 15 min of incubation
(nmol DTT min1 lg1) of sample minus the activity obtained in absence of
SWCNTs. Data are present as mean ± SEM of three independent experiments each
one by triplicate for each condition.
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as redox indicator. HUVECs treated with pristine SWCNTs (0.01–
50 lg/ml) for 2 h showed a statistically signiﬁcant increase in
oxidative stress that peaked at 5 lg/ml, then decreased at higher
concentrations (Fig. 4), where cell viability was clearly affected at
50 lg/ml SWCNT.Fig. 4. Effect of SWCNTs on the cellular REDOX state. The cellular REDOX state was
measured by the detection of H2DCFDA ﬂuorescent signal continuously for 2 h in
HUVECs by ﬂow cytometry. The graph shows the increase in the percent of
oxidative stress at the different concentration of SWCNTs compared to untreated
control. Data are present as mean ± SEM of three independent experiments each
one by triplicate for each condition. ⁄Statistically signiﬁcant compared to untreated
control at p < 0.05 by one-way ANOVA/Dunnet’s post-test.3.5. SWCNT-internalization into endothelial cells
The uptake of SWCNTs by HUVEC was visualized by TEM.
HUVECs were exposed to 5 or 25 lg/ml SWCNTs for 24 h, then,
HUVECs were collected and observed under TEM. The micrographs
show that once inside the cell, SWCNTs tend to aggregate and form
bundles that look like electron-dense particles mainly in the cyto-
sol and into endocytic vesicles (Fig. 5). At 25 lg/ml, SWCNTs
caused vacuole enlargement and the disorganization of mitochon-
dria (Panel B) and accumulated in the cytosol, forming aggregates
(Panel C). A control cell is shown in Panel A.
HUVEC-treated (25 lg/ml) preparations were observed under
High-Angle Annular Dark Field (HAADF) Scanning Transmission
Electron Microscopy (STEM) and Bright Field (BF)-STEM (Fig. 6).
Micrographs were taken at different magniﬁcations and showed
the presence of SWCNTs in the cytosol near the cell membrane
(Panels A–C), which was conﬁrmed by high resolution (Panels D
and E).3.6. SWCNT effects on ﬁbrinolysis genes and anti-oxidant prevention
The effect of SWCNTs (5 or 25 lg/ml) on the Serpine-1, PLAT,
PLAU and KLK1 expression was investigated in HUVEC. TNF-a
was used as a positive control for endothelial activation, and
Trolox (50 lg/ml) was used as an antioxidant. The expression of
the four genes investigated increased between 6 and 12 h after
the addition of SWCNTs to HUVEC, and the intensity and duration
of the response was speciﬁc for each gene.
Treatment with SWCNTs increased the expression of ﬁbrinoly-
sis genes. (1) Serpine-1 increased 5- and 3.2-fold between 6 and
12 h after treatment with 5 lg/ml, respectively, and 3- to 14.5-fold
when treated with 25 lg/ml at the same time points, then
decreased to 0.7-fold compared to control values by 24 h. When
Trolox was added to the treated HUVEC, the SWCNT effects were
prevented. TNF-a increased Serpine-1 expression 4-fold by 24 h
(Fig. 7A). (2) PLAT expression increased 4- to 10-fold by 3 and 6 h
after SWCNT treatment (5 lg/ml) to HUVEC, respectively.Fig. 3. Effect of 24 h exposure to SWCNTs on HUVEC viability using propidium
iodide staining. Fluorescence values were normalized to control values. Data are
present as mean ± SEM of three independent experiments each one by triplicate for
each condition. ⁄Statistically signiﬁcant compared to untreated control at p < 0.05
by one-way ANOVA/Dunnet’s post-test.Treatment with higher concentrations of SWCNTs resulted in 7-
fold increases by 12 h after treatment and was almost negligible
by 24 h at any of the treatments assayed. The addition of Trolox
to HUVECs treated with SWCNTs (5 lg/ml) prevented the increases
in PLAT expression, except at 6 h, when a 2.5-fold increase was
observed. The addition of TNF-a to HUVECs increased PLAT expres-
sion 13-fold at 6 h after SWCNT treatment, then decreased it to 2-
fold by 12 h, and the effect was almost negligible by 24 h (Fig. 7B).
(3) In contrast, SWCNTs (5 lg/ml) added to HUVEC resulted in a
modest 1.5- to 1.8-fold increase in PLAU expression by 3 and
12 h, respectively, whereas HUVEC exposed to 25 lg SWCNT/ml
increased PLAU expression 3.3-fold by 12 h only, with a return to
control values by 24 h. Trolox prevented any effect on PLAU expres-
sion in all SWCNT-treated HUVEC. The addition of TNF-a to HUVEC
did not signiﬁcantly increase PLAU expression (Fig. 7C). (4) Finally,
KLK1 expression was increased 4.8- and 1.8-fold at 6 and 12 h after
5 lg/ml addition to HUVEC, respectively. When treated with
25 lg/ml, the increases were 2.6-fold and twice at 6 and 12 h,
respectively. By 24 h, the expression levels were similar to control
values. Trolox was co-administered with SWCNTs (5 lg/ml) and
observed 12 h afterward. KLK1 expression increased approximately
1.2-fold. TNF-a decreased KLK1 expression 0.5-fold at the 3 h time
point; then, expression increased 2.2-, 5.6- and 18-fold at 6, 12 and
24 h after treatment, respectively (Fig. 7D).3.7. SWCNT-effects on ﬁbrinolysis proteins and anti-oxidant effects
The effect of SWCNTs (5 or 25 lg/ml) on PAI-1, tPA and uPA
levels was investigated in HUVEC. Trolox (50 lg/ml) was used as
an anti-oxidant, and TNF-a was used as a positive control for
endothelial activation.
The SWCNT treatment had several effects on the ﬁbrinolysis
proteins. (1) SWCNT (5 and 25 lg/ml) increased PAI-1 content
1.5-fold. The addition of Trolox (50 lg/ml) to SWCNT-treated
HUVEC caused different responses: at 5 lg/ml, a 2.4-fold increase
was observed; in contrast, 25 lg/ml caused a 0.4-fold decrease.
TNF-a caused a slight, but statistically signiﬁcant PAI-1 increase
(Fig. 8A). (2) tPA levels in HUVEC exposed to SWCNTs (5 and
25 lg/ml) were decreased 0.4-fold. The addition of Trolox
decreased tPA 0.65-fold, and TNF-a decreased t-PA 0.8-fold
(Fig. 8B). (3) Finally, in HUVEC exposed to SWCNTs (5 lg/ml),
uPA levels increased 1.5-fold, whereas 25 lg/ml caused no change.
A B
C
N
N
Fig. 5. Internalization of SWCNTs by endothelial cells in HUVEC. TEM of human vein endothelial cells at 24 h after SWCNTs exposure showing nanotubes internalization into
endothelial cells. (A) untreated-control, (B, C) 25 lg/ml. Arrows indicate the presence of CNTs into the cell. M, N, V stands for mitochondria, nucleus and vacuoles,
respectively.
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caused no change (Fig. 8C).4. Discussion
SWCNTs are promising nanomaterials with increasing indus-
trial demand and diversifying applications but with unknown risks
related to human environmental and occupational exposures.
Therefore, we studied the capacity of pristine SWCNTs to change
the cellular redox state and their effects on cell morphology,
speciﬁcally, on the ﬁbrinolysis system in a HUVEC culture. The
pristine SWCNTs physicochemical characteristics and oxidant
properties are also reported.
The synthesis of CNTs consists in producing carbon fragments
that are reconstituted to form tubes in the presence of metallic
catalyst such as Fe, Co, Ni, among other transition metals at high
temperatures (Popov, 2004). Thus, all CNTs produced contain
residual amounts of metals which may be removed, but no puriﬁ-
cation process is totally efﬁcient. By this reason, even puriﬁed CNTs
samples are not completely metal free and also their toxicity will
depend on the redox transition metal used as catalyzer, which will
further participate in oxidative stress process. The oxidative capac-
ity of these commercial and pristine SWCNTs can be attributed to
the SWCNTs themselves, metal catalytic residues and amorphous
carbon. The material used here contained Co (<3%), a transition
metal used as a catalyzer in the fabrication of SWCNTs, thatremains in the nanotube as a contaminant metal either adsorbed
on the surface of the graphene layer or bound into the graphene
net (Banhart, 2009). The synthesis of CNTs requires nanometer-size
metal particles to act as catalyzers (especially transition metals,
due to their electronic structure), where the bonding between
metal and carbon increases with the number of unﬁlled d-orbitals;
also, Ni, Fe and Co, with similar characteristics, have high afﬁnity to
and solubility in the carbon matrix. Conversely, Au or Pd, which
have no unﬁlled d-orbitals, are not useful for CNT-synthesis.
Additionally, metal atoms interact with the graphene layer by
adsorption on the surface or by substitution of one or several car-
bon atoms, where some metals prefer positions above the center of
a hexagon, whereas others prefer positions above a C atom or
bridge sites over the edge of the hexagon; either way, the metal
will retain its redox properties (Ding et al., 2008; Banhart, 2009).
A comparison between the impurities reported by the pristine
SWCNTs supplied and those used in other studies is shown in
Table 2. The SWCNTs used here had characteristics similar to those
used in other studies.
The sharp increase in DTT oxidation by pristine SWCNTs (from
5 lg/ml) could be attributed to the presence of Co (<3%, approxi-
mately 0.15 lg Co/ml), the only transition metal reported by the
supplier. This response is consistent with the DTT loss and ROS
production linked to the metal content in particulate matter
(PM) that ranges from approximately 0.9% to 52.8% (Wang et al.,
2010b; Vidrio et al., 2009; Shen and Anastasio, 2012;
Ntziachristos et al., 2007; Hu et al., 2008; Geller et al., 2006;
Fig. 6. Scanning transmission electron microscopy imaging of SWCNTs internalization by HUVEC. (A, C) HAADF-STEM images of the cell where the selected areas with CNT-
internalized are indicated with a white circle. (B) TEM image of selected area (white circle of ﬁgure A) with the CNT-internalized; (D, E) BF-STEM images of CNT into the cell.
The images show the previous selected areas in white circles indicated in A–C micrographs; imaging with Atomic Resolution Analytical Electron Microscope JEM ARM200F
(JEOL), operated at 80 kV in STEM mode.
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oxidizing agents reported in PM are carbonaceous compounds,
such as polycyclic aromatic hydrocarbons (Li et al., 2003).
Internalization is the ﬁrst event in the toxic process for pristine
SWCNTs and was observed at concentrations starting from 25 lg/
ml onwards, which was similar to results that were previously
reported for different cell types (Zhu et al., 2007; Simon-Deckers
et al., 2008; Sato et al., 2005; Pulskamp et al., 2007; Monteiro-
Riviere et al., 2005; Marangon et al., 2012; Foldbjerg et al., 2014).
CNTs were visualized as aggregates inside the cell, either dispersed
in the cytosol or included into lysosomes (Fig. 5). Despite many
efforts, however, the exact mechanism for the internalization of
CNTs is unclear, but it could be speculated that the process is
dependent on the SWCNT-aggregation status and ﬁber-like shape
and also on the cell type. Although we cannot offer an internaliza-
tion mechanism, several paths can be proposed (Rodriguez-Yanez
et al., 2013; Firme and Bandaru, 2010). Taking into account that
CNTs are ﬂexible, lipid-soluble, hydrophobic, tubular structures
with a diameter between 0.4 and 4 nm, which are smaller than
the pores present in the nuclear membrane, and that they have a
comparable size to other pores that serve as ion channels in the
plasma membrane (Kostarelos et al., 2007), we hypothesized that
in this study, the mechanism of internalization may be carried
out by both endocytosis (due to the presence of aggregates in vesi-
cles) and nanopenetration/diffusion (Rodriguez-Yanez et al., 2013;
Firme and Bandaru, 2010).
SWCNTs decreased HUVEC viability in a concentration-depen-
dent manner as 50 lg/ml decreased viability to approximately
20% compared to the untreated controls. At that concentration
both the formation of aggregates 24 h after exposure and therelease of metal impurities contributed to this effect. The
SWCNT-concentrations used in this work were chosen from pre-
vious studies that demonstrated in vitro alterations at the vascu-
lar/endothelial levels (Walker et al., 2009; Cheng et al., 2011;
Albini et al., 2010). The SWCNT-effects observed here can be
produced by other nanomaterials that are able to cause damage
to endothelial cells with concentrations similar to those used in
this work (Table 3). Although NIOSH recommends an exposure
limit of 1 lg/m3 based on CNT-animal studies (NIOSH, 2013),
environmental monitoring on CNTs in the workplace report sig-
niﬁcant variable concentrations that must also be considered
(Table 4). Thus, the concentration range used in this work is
environmentally relevant, if the CNT-levels measured in different
workplaces are taken into account. Also relevant is the Co con-
tent in SWCNTs because Co alone decreases cell viability
(Table 5).
The ﬁber-like shape of SWCNTs promotes morphological
changes in HUVEC through cell membrane damage. Due to their
shape, the CNT-cell interactions alter cell membrane integrity
and/or cellular biochemical processes and interact with matrix
adhesion proteins that cause membrane changes and/or the dis-
placement of organelles (Tian et al., 2006) (Porter et al., 2007;
Kostarelos et al., 2007). Additionally, SWCNTs cause mitotic dis-
ruption because of their physical similarity (size, shape and aggre-
gation) to the microtubules that form the spindle apparatus
(Sargent et al., 2009). In addition, SWCNTs alter actin structures,
leading to a reduction in cell proliferation (Holt et al., 2010).
Thus, the SWCNT-induced damage to the cells studied in this paper
could be attributed to both the nanotubes themselves and the
presence of Co.
Fig. 7. SWCNTs effect with or without Trolox on the relative expression of Serpine-1-, PLAT-, PLAU- and KLK1-mRNA in HUVEC. Total mRNA was isolated from HUVEC
conﬂuent cultures untreated and exposed to 5 or 25 lg SWCNT/ml plus antioxidant treatment (AOx) in FBS-1% DMEM. (A) Serpine-1-, (B) tPA-, (C) uPA-, and (D) KLK1-mRNA
were measured by real-time RT-PCR at 3, 6, 12 or 24 h of exposure. Data are present as mean ± SEM of three independent experiments each one by triplicate for each
condition. ⁄p < 0.05 and ⁄⁄p < 0.01 compared to untreated control by Kruskal–Wallis one-way ANOVA/Dunn’s post test.
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Fig. 8. SWCNTs effect with or without Trolox on Fibrinolysis-protein levels in HUVEC. The cell culture supernatants both of control and SWCNTs (5 or 25 lg/ml)-treated cells,
plus antioxidant treatment (AOx) 12 h after exposure. (A) PAI-1, (B) tPA and (C) uPA levels were detected by commercially available ELISA kits and according to the
manufacturer instructions. Data are present as mean ± SEM of three independent experiments each one by triplicate for each condition. ⁄p < 0.05 and ⁄⁄p < 0.01 compared to
untreated control by one-way ANOVA/Dunnet’s post-test.
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tent caused an increase in the oxidative stress at 5 lg/ml and
above and peaked at 25 lg/ml. Changes in redox state could be
related to a direct effect of the SWCNTs on the inner membrane
of mitochondria, causing a depolarization that is attenuated by
antioxidants (He et al., 2012). In addition to this, the Co contam-
ination present in the SWCNTs may undergo redox cycles, generat-
ing OH and other reactive oxygen species through Fenton
reactions (Leonard et al., 1998; Jomova and Valko, 2011).
Additionally, ROS formation is associated with metals bound to
graphene layers, but also to metals leached from CNTs that reduce
antioxidant levels (Ge et al., 2012). Therefore, we demonstrated
that the oxidative stress increased as the concentration of
SWCNTs increased in exposed HUVEC. This increase may stimulate
antioxidant activities in the cell, such as GSH increases; however,
when ROS production overwhelms the compensation limit, an irre-
versible damage is produced (Guo et al., 2011). Finally, concentra-
tions higher than 50 lg/ml slightly decreased the oxidative stress,
most likely because cell viability is compromised not only by ROS,
but also by the physical interference of CNTs with cellular
components.
Because SWCNTs have proved to be able to interact either
directly or through the leached metals adsorbed or integrated into
the graphene matrix, it could be expected that they may exert toxi-
city in the place where they are located; thus, the ﬁbrinolysis sys-
tem (FS) will be affected in ECs when exposed to CNTs.
TEM showed that SWCNTs are internalized into ECs. For this
reason, in humans or in vivo systems, SWCNTs could be translo-
cated from airways or the lung into the general circulation; there-
fore, the vasculature becomes a primary target (Nemmar et al.,
2002, 2004). Such translocation is favored by the proximitybetween lung epithelial type 1 cells and the caveolar membrane
of the endothelial cells (Heckel et al., 2004). In addition, there is
a direct interaction between CNTs, erythrocytes and other blood
elements that may contribute to the risk of suffering thrombotic/
atherothrombotic injuries.
On other hand, the FS plays a key role in the dissolution of blood
clots and the prevention of intravascular thrombosis; thus, its
imbalance is involved in the pathophysiology of cardiovascular
ischemia and endothelial dysfunction. In addition, this system is
also involved in diverse pathologic conditions, such as the forma-
tion and progression of cancer, pathogen virulence, airway disease,
metabolic disease, chronic inﬂammatory diseases and others
(Rein-Smith and Church, 2014).
In this study, we demonstrated that the exposure of HUVEC to
SWCNTs alters gene expression and protein levels involved in
ﬁbrinolysis, such as tPA, uPA, KLK1 and PAI-1, the latter being
the major ﬁbrinolysis physiological regulator (Binder et al., 2002).
We show that the expressions of the main genes involved in FS
were affected by SWCNT-exposure compared to untreated control
cells, as shown by the Serpine-1-, PLAT-, PLAU- and KLK1-mRNA
increases in the ﬁrst 12 h. These expressions were diminished to
levels even lower than the controls after a 24 h treatment. These
results are in agreement with those showed previously (Erdely
et al., 2009), where it was demonstrated that SWCNTs and
MWCNTs deposited in the lung of treated mice. Such deposition
activated acute local and systemic responses characterized by
changes in blood genes and protein expressions, which, in turn,
induced cardiovascular damage. In this study, the SWCNTs used
were 0.8–1.2 nm in diameter and 0.1–1 lm in length, and included
8.8% Fe content, and the concentrations were similar to those used
in this study. Although this was an in vitro study, it agrees with the
Table 3
Effects produced by different types of nanomaterials on endothelial cells.
Nanomaterial Concentration Cell culture Effects References
Fe2O3-, Y2O3-,
CeO2-, ZnO-NP
0.001–50 lg/ml HAEC Inﬂammatory response and ROS production with Ce- and Zn-
NP above 10 lg/ml
Gojova et al. (2007)
Loss of adherence with ZnO-NP
Fe2O3-NP 50 lg/ml HMVEC Increased cell permeability and stabilization of microtubules
through ROS and AKT/GSK-3b
Apopa et al. (2009)
SWCNT, MWCNT,
carbon black
(CB)-NP
10–150 lg/106 cells HAEC Actin ﬁlaments, VE cadherin disruption, citotoxicity, reduced
tubule formation only with CNTs
Walker et al. (2009)
Fe2O3-NP 0.1–100 mM HUVEC Concentration-dependent loss of cell viability. Cytoskeleton
and related functional alterations. Cell migration/invasion
inhibition
Wu et al. (2010)
Pristine-SWCNT
COOH-MWCNT
12.5–800 lg/ml HUVEC-EC-C Both SWCNT and MWCNT induce toxic effects. CNT
functionalization and toxicity
Gutierrez-Praena et al.
(2011)
Fe2O3-NP Fe3O4-
NP
2–100 lg/ml HAEC Increased surface expression of intracellular ICAM-1 and
vascular adhesion molecules-1 (VCAM-1) at 100 lg/ml.
Increased ROS production and damage to cell membranes
Zhu et al. (2011)
CB-NP 0–100 lg/ml HUVEC Inhibition of proliferation, apoptosis and necrosis (from 5 lg/
cm2). Endothelial activation with increase of adhesion and
inﬂammatory molecules. ROS and NO production. NF-jb
pathway activation
Vesterdal et al. (2012)
TiO2-NP 5–40 lg/cm2 HUVEC Inhibition of proliferation, apoptosis and necrosis (from 5 lg/
cm2). Endothelial activation with increases on adhesion and
inﬂammatory molecules. ROS and NO production. NF-jb
pathway activation
Montiel-Davalos et al. (2012)
MWCNT 1 or 10 lg/ml HAEC Increase on mRNA transcripts for VCAM-1, SELEICAM-1, and
CCL2 in MWCNT with surfactant
Vidanapathirana et al. (2012)
MWCNT 2.5 lg/ml HMVEC Increase on cell permeability, migration and ROS production
with actin ﬁlament remodeling. Induction of MCP-1 and
ICAM-1
Pacurari et al. (2012)
Silica NP 1  103 – 6  104 NP
per cell/100 ll
HUVEC NP-uptake via clatrin dependent pathway. Decrease of
mitochondrial activity. Cell dead for HUVEC
Blechinger et al. (2013)
(SIO3-310-P)
(SIO2-304)
HeLA
Silica NP 25–100 lg/ml HUVEC ROS production, oxidative damage and malondialdehyde
production. Inhibition of SOD and GPX. Necrosis and
apoptosis after 24 h. Decrease of mitochondrial membrane
potential. DNA damage. G2/M arrest via Chk1-dependent
Duan et al. (2013)
MWCNT 1.32 lg/ml SAEC/HMVEC Increase in phospho-NF-jb/Stat3- and p38 MAPK through
ROS. Actin rearrangement. Loss of VE-cadherin. Increase of
angiogenic ability, as well as VEGFA, sICAM-1 and sVCAM-1
Snyder-Talkington et al.
(2013)
Pristine SWCNT 01–50 lg/ml HUVEC primary
cultures
Citotoxicity, cell damage, ROS increases, ﬁbrinolysis- related
gene and proteins alterations
This study
Table 4
CNT mass concentration in working environments.
CNT
sample
Place Concentration measured
(lg/m3)
References
MWCNT AS 36.6–331.7 Han et al. (2008)
MWCNT AS 12.6–187.3 Lee et al. (2010)
PBZ 7.8–320.8
MWCNT PBZ 0.8–7.86 Dahm et al.
(2012)AS 0.47–4.62
SWCNT PBZ 0.68–3.28
AS 0.82–1.13
SWCNT Gloves 0.2–6  103* Maynard et al.
(2004)Personal air
sample
0.7–53
SWCNT PBZ 38 Methner et al.
(2012)
MWCNT AS 10–3468 Dahm et al.
(2013)SWCNT 10–83
MWCNT PBZ 10.6 Erdely et al.
(2013)
MWCNT AS <430–6800 Hedmer et al.
(2014)
Abbreviations: AS (area sample); PBZ (personal breathing zone).
* mg per hand.
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ﬁbrinolysis pathway. Likewise, all mRNA studied were similarlyaffected by SWCNT-exposure because they all share cis-regulatory
elements in their promoter, such as CCAAT box-binding transcrip-
tion factor (CTF)/nuclear factor 1 (NF1), upstream stimulatory fac-
tors 1 and 2 (USF1/2), Smad2 and Smad3, CREB-binding protein
(CBP) and speciﬁcity protein 1 (Sp1), as well as numerous tran-
scription factors, including C/EBP, AP-1, C-FOS, C-JUN, NF-jB,
SREBP, CREB, PPARc, STAT. Additionally, it is important to note that
some factors in the mitogen-activated protein kinase (MAPK) path-
way are redox-sensitive (see reviews:(Nagamine, 2008; Irigoyen
et al., 1999)). In this work, co-treatment with the antioxidant
Trolox decreased the mRNA expression levels in HUVEC-treated
cells. Additionally, TNF-a, a positive endothelial dysfunction con-
trol, increased the mRNA expression, but in a smaller proportion
than the SWCNT-exposure concentrations used here. This fact
may explain the possible participation of ROS produced by
SWCNT-exposure because they are involved in the activation of
AP-1 and NF-jB. AP-1 is one of the transcription factors involved
in the oxidative stress response after changes in the cellular oxida-
tive status. In this respect, AP-1 has been identiﬁed as a target of
the MAPK family, which includes ERKs, JNKs, and p38 kinase
(Karin et al., 1997). In addition, the activation of NF-jB has been
shown to be regulated by some upstream MAPKs that regulate
JNK activation in the cells (Ding et al., 2001). Hence, it was
previously demonstrated that SWCNT exposure in human lung
ﬁbroblasts induces ROS generation and activates PARP, AP-1,
NF-jB, p38, and AKT in a dose-dependent manner (Azad et al.,
2013). Therefore, some of these pathways may be activated by
Table 5
Co concentrations and its effect on cell viability.
Sample Cell line Metal or residue % WT Sample and metal concentration Effect (after 24 h of exposure) References
CoCl2 (solution) SHSY5Y Co2+ NA 500 lM (containing
24.96  103 mg/ml of Co2+)
Cell viability (%) 23.43 ± 2.21 and
57.93 ± 3.47, respectively
Stenger et al. (2011)
SKNBE(2c)
SWCNT-3 A549 Fe2+, Co2+, Mo2+ 9.3, 4.8, 1.2 10 lg/ml (containing 0.93 lg/ml
of Fe2+, 0.48 lg/ml of Co2+ and
0.12 lg/ml of Mo2+)
Loss of cell viability (>20%) Ge et al. (2012)
SWCNT HUVEC Co2+ <3 50 lg/ml (containing <1.5 lg/ml
of Co2+)
Loss of cell viability (>20%) This study
Co2+ NIOSH REL: TWA 0.05 mg/m3.
Fig. 9. Possible mechanism for cell damage, oxidative stress and alteration of SWCNTs on endothelial ﬁbrinolysis-related genes and protein. (A) SWCNT-uptake to the cell by
nanopenetration or passive transportation occurring when CNT crosses through the cell membrane; (B) SWCNT caveole-mediated endocytosis. (C) Extracellular SWCNT-
metal leached. (D) Uptake of leached metals from SWCNT into the cell by transporters (i.e. metal transporter-1 for Co). (E) SWCNT-endocytosis and enhanced Co release in
endosome and lysosome. (F). Fenton reaction by leached metals of SWCNTs (Co), increases in ROS production and then oxidative stress. (G) Chemical-mitochondrial damage
by ROS and physical-mitochondrial damage by the SWCNTs structure. (H) Activation of some pathways by ROS and the consequent translocation of transcription factors. (I)
Transcription of serpine-1-, PLAT-, PLAU- and KLK1-mRNA. (J) mRNA translation and differential synthesis of PAI-1, tPA and uPA, which are secreted to extracellular medium.
(K) PAI-1, the most abundant and synthetized protein and the primary inhibitor of both tPA and uPA. A functional defect or an insufﬁcient ﬁbrinolysis response may lead to
thrombosis with severe or fatal clinical consequences. (L) Thrombus may interact also with CNTs and increase their half-life and subsequently, form an occlusive arterial
thrombi.
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expressions of the genes evaluated. An illustration of the
possible pathways affected by SWCNT-exposure is proposed in
Fig. 9.Therefore, the protein level analysis shown that PAI-1 had the
highest levels, and its rise in expression was concentration-depen-
dent in HUVEC treated with SWCNTs; however, tPA protein levels
decreased, and uPA did not show signiﬁcant changes. TNF-a, a
1212 Y. Rodríguez-Yáñez et al. / Toxicology in Vitro 29 (2015) 1201–1214positive control, increased PAI-1 but did not increase tPA or uPA
levels. Antioxidant co-treatment also diminished the protein
levels, with the exception of PAI-1 at 5 lg/ml SWCNTs. The biologi-
cal role of PAI-1 largely depends on its levels of expression, as well
as its activity. PAI-1 is expressed in ECs and is regulated at the tran-
scriptional, post-transcriptional and post-translational levels. PAI-
1 gene expression is tightly regulated by a variety of cytokines
and growth factors, including thrombin, endotoxin, dexametha-
sone, interleukin-1, transforming growth factor b (TGF-b) and
TNF-a (van Hinsbergh et al., 1988; Nagamine, 2008; Kruithof,
1988). Hence, we used the latter as a positive control to induce
endothelial activation, using the overexpression of PAI-1 as an
indicator. Also of consideration is that high PAI-1 plasma concen-
trations have been shown to considerably shorten the tPA half-life
in circulation and may lead to decreased ﬁbrinolysis activity
(Wiman, 2000). Although we used an in vitro system, we hypothe-
sized that PAI-1 is secreted from HUVEC and increasing its level,
which in turn, inhibits tPA and uPA proteins as indicated by the
low levels observed here (Fig. 8).
5. Conclusion
The cytotoxicity of commercial and pristine SWCNTs in HUVEC
may be related to the oxidative capacity of both CNTs and Co, the
latter of which is an active ROS generator that acts through Fenton
reactions. Our results suggest that SWCNTs were able to alter the
expression of genes and proteins involved in ﬁbrinolysis, which
in turn may cause an endothelial dysfunction and develop a pro-
thrombotic effect. These results may help to foresee possible
pathologies caused by these novel materials. However, further
mechanistic studies are needed to fully elucidate the effects of
pristine-commercial SWCNTs on ECs to better understand and
deﬁne the sequence of molecular events and regulatory mecha-
nisms involved in SWCNT-induced endothelial dysfunction and
ﬁbrinolysis pathway alterations.
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